Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
“The pre-existing manual, analog system is no longer sustainable in meeting the ever-increasing demand for IVF and egg freezing, and technology and innovation is critical to continued scale and safety. TMRW’s platform enables the field to safely support the hundreds of millions of IVF births projected over the remainder of this century.” Tara Comonte, CEO of TMRW.
Highlights
TMRW Life Sciences raises $105M to accelerate the global rollout of its automated platform for IVF egg and embryo management.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
